Microglial xCT Is a Novel Therapeutic Target for Traumatic Brain Injury in Model Mice
Thus, microglial xCT is important in the pathology of brain injury accompanied by bleeding and is considered a promising therapeutic target.
Authors
- Kazuomi Nakamura (ORCID: https://orcid.org/0000-0003-3532-2395)
- Yugo Kato (ORCID: https://orcid.org/0000-0002-8357-0986)
- Kazuhiro Nakaso
- Makoto Sakamoto (ORCID: https://orcid.org/0009-0003-8805-4440)
- Yosuke Horikoshi (ORCID: https://orcid.org/0000-0001-6587-644X)
- Yuji Nakayama (ORCID: https://orcid.org/0000-0001-7882-0066)
- Hideyo Sato (ORCID: https://orcid.org/0000-0002-3732-7344)
- Kenichi Matsuda
- Takahiro Ueda (ORCID: https://orcid.org/0000-0002-7404-2663)
- M. Homma (ORCID: https://orcid.org/0009-0005-1836-128X)
- Y. Okawara
Institutions
- Tottori University Hospital (JP)
- Tottori University (JP)
- Niigata University (JP)
Publication Details
- Journal
- Yonago acta medica
- Published
- 2025-01-01
- DOI
- https://doi.org/10.33160/yam.2025.08.011
- Citations
- 1
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.84
Funders
- Japan Society for the Promotion of Science